ALB and neoplasm: Herein, we propose cathepsin B-overexpressed tumor cell activatable albumin-binding doxorubicin prodrug, Al-ProD, which can effectively deliver anticancer drugs by in situ albumin-mediated passive targeting with minimal side effects.